Publications & Media
Peer-Reviewed Journal Articles
2024
• The patient perspective on dose optimization for anticancer treatments: A new era of cancer drug dosing—Challenging the “more is better” dogma – Clinical Trials2023
• The Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life – JCO Oncology Practice2022
• Patient-centered dosing: Oncologists’ perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC) – Breast Cancer Research and Treatment
Media & News Coverage
2025
ASCO Connection, January 2025
Pharmacy Times, January 2025
2024
Healio, October 2024
Medscape, September 2024
NCI Cancer Currents, June 2024
Breastcancer.org article, 2024
2021
Breastcancer.org article, June 2021
Medscape, December 2021
Oncology Nurse Advisor, October 2021
Living Beyond Breast Cancer, June 2021
Cancer Today, July 2021
After 20 Years, July 2021
MED SHADOW, Sept. 2021
2020
Cancer Today, Oct. 2020
Cancer Therapy Advisor, Feb. 2020
Talks & Podcasts
May 1, 2022 – Health Design Podcast with Sheila McGlown and Julia Maués – Listen here
June 2021 – ASCO 2021 Summary by Dr. Lisa Carey – Watch here (starts at minute 19:40)
FDA & Conference Engagements
Nov. 2021 – Friends of Cancer Research Annual Meeting: PCDI joins national stakeholders in a pivotal discussion on optimizing dose in oncology drug development – Watch here
March 2022 - FDA OCE Conversations on Cancer – “More Isn’t Always Better: Understanding Cancer Treatment Tolerability” – Watch here